1-3 of 3
Leila Mekkaoui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antigen Receptor

Anne Marijn Kramer, MD, Sara Ghorashian, MD PhD FRCPath, Gordon Weng-Kit Cheung, MSc, Winston Vetharoy, BVSc, Dale Moulding, PhD, Leila Mekkaoui, MSc, Shimobi Onuoha, PhD, Persis J Amrolia, Professor, Martin A Pule, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1627.
https://doi.org/10.1182/blood.V128.22.1627.1627
Published: 2016
Journal Articles

Use of CD 123 Expression on Blasts from AML, ALL and RAEB As Minimal Residual Disease Marker

Leila Mekkaoui, Celine Rassart, Laurence Rozen, Anne Janssens, Dominique Bron, MD PhD, Alina Ferster, MD PhD, Brigitte Cantinieaux, MDPhD
Journal: Blood
Blood (2015) 126 (23): 5402.
https://doi.org/10.1182/blood.V126.23.5402.5402
Published: 2015
Journal Articles

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy

Brian Philip, Evangelia Kokalaki, Leila Mekkaoui, Simon Thomas, Karin Straathof, Barry Flutter, Virna Marin, Teresa Marafioti, Ronjon Chakraverty, David Linch, Sergio A. Quezada, Karl S. Peggs, Martin Pule
Journal: Blood
Blood (2014) 124 (8): 1277–1287.
https://doi.org/10.1182/blood-2014-01-545020
Published: 2014
Includes: Supplemental data